The best Bull and Bear pitches based on recency and number of recommendations.
In December this stock nearly doubled after the company issued a PR claiming that the EMA provided them with positive regulatory feedback regarding the proposed phase III trial of ICT-107. I read the PR a few times and I'm not sure whether it… More
ImmunoCellular is yet another dubious outfit that refuses to die after a crushing failure in a clinical trial. The share price bottomed out at 0.72 subsequent to negative results of the phase II trial of ICT-107 in GBM. No statistically significant… More
Read the most recent pitches from players about IMUC.
Recs
zz
Recs
It is going to hit 6 dollars by the end of 2014.
Biotechnology is on the rise.
Recs
according to the company, we can expect results from the ict-107 phase II trail.
Find the members with the highest scoring picks in IMUC.
hendrixharlow (85.25) Score: +461.80
The Score Leader is the player with the highest score across all their picks in IMUC.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
hendrixharlow | 85.25 | 9/22/2011 | 5Y | $688.00 | -99.93% | +361.87% | +461.80 | 0 Comment | ||
Ruckwerts | 20.12 | 9/30/2011 | 3M | $612.00 | -99.92% | +355.56% | +455.47 | 0 Comment | ||
BuffettJunior1 | 99.74 | 9/27/2011 | 5Y | $600.00 | -99.92% | +338.23% | +438.14 | 1 Comment | ||
icrazy | < 20 | 10/21/2011 | 1Y | $560.00 | -99.91% | +323.09% | +423.00 | 0 Comment | ||
mdicksonjr | 86.82 | 11/14/2012 | 5Y | $624.00 | -99.92% | +281.11% | +381.03 | 0 Comment | ||
Schimmyboy | 21.71 | 7/30/2012 | 3Y | $1,296.00 | -99.96% | +276.77% | +376.73 | 0 Comment | ||
brian3305 | < 20 | 10/19/2012 | 1Y | $840.00 | -99.94% | +259.37% | +359.31 | 0 Comment | ||
BigD24359 | < 20 | 11/22/2016 | 5Y | $33.00 | -98.45% | +137.21% | -235.66 | 0 Comment | ||
sk2129 | 30.48 |
|
5Y | $227.52 | -99.78% | +147.08% | -246.86 | 1 Comment | ||
dippinmytoes | 33.36 | 8/5/2014 | 3M | $379.52 | -99.87% | +171.01% | -270.87 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.